Restless Brush Syndrome: Lessons for Requip Marketers
Restless Leg Syndrome (RLS) has been receiving a lot of attention these days because of all the recent Requip TV ads and in-office patient pamphlets. See, for example, "Restless Pharma Marketing."Little...
Drug Risks: Consumers Less Concerned than Docs
On March 31, 2006, the Coalition for Healthcare Communication (CHC) -- comprised of major advertising, marketing and PR organizations, including the American Association of Advertising Agencies, the Association of National Advertisers,...
Pharma Use of Rx Data Survey
THE ISSUELimiting Pharma Access to Physician Prescribing DataPharmaceutical companies use physician prescribing data for a variety of purposes, but arguably mostly for sales and marketing purposes.Some doctors object to the use...
Pharma Tail Wags Patient Dogs
There's no doubt that pharmaceutical marketers have deep penetration into patient advocacy groups. As reported recently in the Philadelphia Inquirer: Although patients seldom know it, many patient groups and drug companies...
How to Piss Off KOLs
Key Opinion Leaders -- or KOLs as they are known by pharmaceutical marketers -- are physicians who influence their peers' medical practice, including but not limited to prescribing behavior. Pharmaceutical companies...
FDA Gets a “C” from the Public
Seems like a lot of Harris/Wall Street Journal polls are crossing my path lately (see, for example, "Doing a Good Job but Still No Respect!"). The latest one, about the public's...
Doing a Good Job but Still No Respect!
The late, great comedian Rodney Dangerfield made the phrase "I get no respect" his trademark. Some pharmaceutical executives these days have embraced the Rodney Dangerfield shtick. Henry McKinnell, Pfizer's CEO, for...
More Reminder Ad Sightings
Reports of the demise of pharmaceutical "reminder ads" (eg, "Reminder Ads - Pharma's Dodo?") have been greatly exaggerated.Since PhRMA's Guiding Principles for Direct to Consumer Advertising became effective in January, 2006,...
Proper Pharma Use of Rx Data
Yesterday I posted a critique of an article in the May 2006 issue of the venerable Pharmaceutical Executive Magazine, affectionately known as PE to its loyal readers, of whom I consider...
Specious Arguments in Favor of Rx Data Use
IMS Health -- the company that sells physician prescribing data to pharmaceutical companies -- is working overtime these days to stem the rising tide against the use of physician prescribing data...
